http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100761222-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A45F2200-0516 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A45F2005-006 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A44B11-2584 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A45F5-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30 |
filingDate | 2006-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2007-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2007-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-100761222-B1 |
titleOfInvention | Vanilloid receptor antagonists to prevent and treat drug-dependent addiction |
abstract | The present invention relates to the prevention and treatment of adverse effects by abused drugs. In particular, the present invention relates to a medicament effective for preventing or treating dependence and spontaneous exercise by drugs acting on vanilloid receptors. The administration of capsazepine acting on the vanilloid receptor used in the present invention exhibits a strong dependence-improving effect on the cocaine-dependent poisoning formation and relapse process. Therefore, the administration of the drug acting on the vanilloid receptor according to the present invention provides important information for the development and prevention of drug-dependent poisoning.n n n n Capsazepine, drug-dependent poisoning, vanilloid receptor |
priorityDate | 2006-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.